Validation of a next-generation-sequencing heme clinical assay for detection of immunoglobulin heavy chain clonality and somatic hypermutation in chronic lymphocytic leukemia Read more about Validation of a next-generation-sequencing heme clinical assay for detection of immunoglobulin heavy chain clonality and somatic hypermutation in chronic lymphocytic leukemia
Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment Read more about Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment
Ubiquitin ligases implicated as predictive biomarkers for poor outcome to immunotherapy in melanoma patients Read more about Ubiquitin ligases implicated as predictive biomarkers for poor outcome to immunotherapy in melanoma patients
Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay Read more about Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay
Pattern of PIK3CA co-alterations in endometrial cancer Read more about Pattern of PIK3CA co-alterations in endometrial cancer
Obesity-Induced Changes in the Tumor Microenvironment Impact the Response to Chemotherapy and Overall Ovarian Cancer Metastatic Success Read more about Obesity-Induced Changes in the Tumor Microenvironment Impact the Response to Chemotherapy and Overall Ovarian Cancer Metastatic Success
Molecular profiling of RUNX1/RUNT domain in myeloid disorders Read more about Molecular profiling of RUNX1/RUNT domain in myeloid disorders
Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development Read more about Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development
Dual approach using proteomics and multiplexed immunofluorescence for the detection of markers predictive for immunotherapy in melanoma patients Read more about Dual approach using proteomics and multiplexed immunofluorescence for the detection of markers predictive for immunotherapy in melanoma patients
Custom PhenoImager™ fluorescent multiplex IHC panel identifies mature tertiary lymphoid structures in colorectal cancer Read more about Custom PhenoImager™ fluorescent multiplex IHC panel identifies mature tertiary lymphoid structures in colorectal cancer